Evidence map›Paper›PMID 38958282›Full record

ArticleJournal of neurophysiology2024

Dopamine enhances GABA

Nikolas Bergum, Casey-Tyler Berezin, Jozsef Vigh

Abstract read
In one paragraph

Article in Journal of neurophysiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Nikolas BergumDepartment of Biomedical Sciences, Colorado State University, Fort Collins, Colorado, United States.ORCID 0000-0003-2474-4912
Casey-Tyler BerezinCell and Molecular Biology Graduate Program, Colorado State University, Fort Collins,Colorado, United States.ORCID 0000-0001-7201-8929
Jozsef VighDepartment of Biomedical Sciences, Colorado State University, Fort Collins, Colorado, United States.ORCID 0000-0001-9862-5049

Funding

Opioid Modulation of Retinal Ganglion Cells Providing Photoentrainment of the Circadian ClockR01EY029227 · NEI · COLORADO STATE UNIVERSITY · PI Jozsef Vigh · 2019 to 2026
$2.6M
HHS | NIH | National Eye Institute (NEI) RO1EY029227NEI NIH HHS R01 EY029227
6 · The paper itself

Abstract

Neuromodulation in the retina is crucial for effective processing of retinal signal at different levels of illuminance. Intrinsically photosensitive retinal ganglion cells (ipRGCs), the neurons that drive nonimage-forming visual functions, express a variety of neuromodulatory receptors that tune intrinsic excitability as well as synaptic inputs. Past research has examined actions of neuromodulators on light responsiveness of ipRGCs, but less is known about how neuromodulation affects synaptic currents in ipRGCs. To better understand how neuromodulators affect synaptic processing in ipRGC, we examine actions of opioid and dopamine agonists have on inhibitory synaptic currents in ipRGCs. Although µ-opioid receptor (MOR) activation had no effect on γ-aminobutyric acid (GABA) currents, dopamine [via the D1-type dopamine receptor (D1R)]) amplified GABAergic currents in a subset of ipRGCs. Furthermore, this D1R-mediated facilitation of the GABA conductance in ipRGCs was mediated by a cAMP/PKA-dependent mechanism. Taken together, these findings reinforce the idea that dopamine's modulatory role in retinal adaptation affects both nonimage-forming and image-forming visual functions.

Indexed as

DopamineReceptors, GABA-ARetinal Ganglion CellsAnimalsDopamine AgonistsFemaleInhibitory Postsynaptic PotentialsMaleMiceMice, Inbred C57BLReceptors, Dopamine D1Receptors, Opioid, muDopamineDopamine AgonistsReceptors, Dopamine D1Receptors, GABA-AReceptors, Opioid, mudopamineelectrophysiologyretinaγ-aminobutyric acid (GABA)µ-opioid receptor (MOR)

Identifiers

PMID38958282
PMCPMC11427049

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.